eMed vs MarketAxess

Side-by-side comparison of AI visibility scores, market position, and capabilities

MarketAxess leads in AI visibility (70 vs 48)
eMed logo

eMed

ChallengerDigital Health

Metabolic Health

Raised $200M Series A (Mar 2026) at $2B+ valuation led by AON Consulting. 91%+ medication adherence. GLP-1 benefits platform for employers. Linda Yaccarino CEO.

AI VisibilityBeta
Overall Score
C48
Category Rank
#1 of 1
AI Consensus
52%
Trend
up
Per Platform
ChatGPT
41
Perplexity
54
Gemini
58

About

eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.

Full profile
MarketAxess logo

MarketAxess

LeaderConsumer Finance

Enterprise

New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.

AI VisibilityBeta
Overall Score
B70
Category Rank
#13 of 290
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
65
Perplexity
65
Gemini
68

About

MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.

Full profile

AI Visibility Head-to-Head

48
Overall Score
70
#1
Category Rank
#13
52
AI Consensus
79
up
Trend
stable
41
ChatGPT
65
54
Perplexity
65
58
Gemini
68
41
Claude
73
44
Grok
65

Capabilities & Ecosystem

Capabilities

Only eMed
Metabolic Health

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.